— Know what they know.
Not Investment Advice

STXS AMEX

Stereotaxis, Inc.
1W: -2.1% 1M: -2.1% 3M: -8.2% YTD: -18.1% 1Y: -9.1% 3Y: +8.0% 5Y: -72.3%
$1.92
+0.02 (+1.05%)
After Hours: $1.91 (-0.01, -0.78%)
Weekly Expected Move ±5.6%
$2 $2 $2 $2 $2
AMEX · Healthcare · Medical - Instruments & Supplies · Alpha Radar Neutral · Power 44 · $187.7M mcap · 69M float · 0.599% daily turnover · Short 62% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$32M +20.3% ▲
5Y CAGR: +4.0%
Gross Profit
$17M +17.0% ▲
5Y CAGR: -2.1%
Operating Income
-$22M +10.6% ▲
Net Income
-$22M +10.0% ▲
EPS (Diluted)
$-0.25 +16.7% ▲
EBITDA
-$21M +13.5% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$35M$28M$27M$27M$32M
YoY Growth+31.5%-19.6%-4.9%+0.5%+20.3%
Cost of Revenue$12M$10M$12M$12M$15M
Gross Profit$23M$18M$15M$15M$17M
Gross Margin66.3%65.6%55.5%54.2%52.7%
R&D Expenses$10M$11M$10M$10M$9M
SG&A Expenses$26M$27M$26M$30M$30M
Operating Expenses$36M$37M$37M$39M$39M
Operating Income-$13M-$19M-$22M-$25M-$22M
Operating Margin-36.8%-66.7%-81.6%-91.9%-68.3%
Interest Expense$10K$0$0$0$0
Income Before Tax-$11M-$18M-$21M-$24M-$22M
Tax Expense$0$0$0$0$0
Net Income-$11M-$18M-$21M-$24M-$22M
Net Margin-30.6%-65.0%-77.4%-89.3%-66.8%
EPS (Diluted)$-0.16$-0.26$-0.27$-0.30$-0.25
EBITDA-$13M-$18M-$21M-$24M-$21M
Shares Outstanding76M76M81M85M91M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms